{"response": {"meta": {"time": 21, "hits": 3, "offset": 0}, "docs": [{"news_desk": "National Desk", "document_type": "article", "_id": "4fd22f1c8eb7c8105d7bd5ac", "headline": {"main": "National Briefing | Science And Health: Obesity Linked To Breast Cancer Risk"}, "pub_date": "2003-08-20T00:00:00Z", "slideshow_credits": null, "source": "AP", "byline": null, "abstract": "Researchers report that obese woman have higher risk of breast cancer compared to normal women, possibly because their fat cells release too much estrogen (S)", "web_url": "http://www.nytimes.com/2003/08/20/us/national-briefing-science-and-health-obesity-linked-to-breast-cancer-risk.html", "section_name": null, "lead_paragraph": "Older women who are obese have a higher risk of breast cancer, possibly because their fat cells release too much estrogen, researchers said. The international study comparing obese women to women of normal weight supports a theory held by many researchers that fat cells release the hormone into the blood, allowing it to help turn normal cells cancerous. The researchers -- Dr. Tim Key of the Cancer Research U.K. Epidemiology Unit at Britain's Oxford University and colleagues in Britain, Italy, Japan and the United States -- reported their findings in this week's issue of the Journal of the National Cancer Institute.", "snippet": "Older women who are obese have a higher risk of breast cancer, possibly because their fat cells release too much estrogen, researchers said. The international study comparing obese women to women of normal weight supports a theory held by many...", "blog": [], "keywords": [{"value": "ESTROGEN", "name": "subject"}, {"value": "WEIGHT", "name": "subject"}, {"value": "BREAST", "name": "subject"}, {"value": "CANCER", "name": "subject"}, {"value": "WOMEN", "name": "subject"}, {"value": "RESEARCH", "name": "subject"}], "print_page": "17", "type_of_material": "News", "word_count": 101, "subsection_name": null, "multimedia": []}, {"news_desk": "Business/Financial Desk", "document_type": "article", "_id": "4fd243838eb7c8105d7dd4d1", "headline": {"main": "2 New Fronts in Heartburn Market Battle"}, "pub_date": "2003-08-20T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By GARDINER HARRIS", "person": [{"lastname": "HARRIS", "rank": 1, "firstname": "Gardiner", "organization": "", "role": "reported"}]}, "abstract": "Novartis says it will soon start selling heartburn drug omeprazole, generic version of Prilosec, even though court has yet to approve sale; aggressive move could open Novartis to huge damages if judge eventually rules that its generic version infringes patents owned by AstraZeneca, which sells Prilosec; Procter & Gamble Co says it will begin selling over-the-counter version of Prilosec on Sept 15, priced about 70 cents per pill, or $22 or so for month's supply (M)", "web_url": "http://www.nytimes.com/2003/08/20/business/2-new-fronts-in-heartburn-market-battle.html", "section_name": "Technology; Health; Business", "lead_paragraph": "Cracks appeared yesterday in a pillar of drug industry profits with twin announcements that users of a huge-selling heartburn drug will soon have alternatives that will be cheaper and easier to buy. As a result, the biggest fight ever seen between managed-care companies and drug makers could soon begin. In the first announcement, Novartis said it would soon start selling omeprazole, the generic version of Prilosec, even though a court has yet to approve the sale. The aggressive move could open Novartis to huge damages if a judge eventually ruled that its generic version infringed patents owned by AstraZeneca, which sells Prilosec. But it also means that consumers will soon save a bundle on the medicine. Prilosec currently sells for $116 for a month's supply on Drugstore.com. A lone generic version introduced in December sells for $100; with more generic entries, analysts said the price could drop to $11.", "snippet": "Cracks appeared yesterday in a pillar of drug industry profits with twin announcements that users of a huge-selling heartburn drug will soon have alternatives that will be cheaper and easier to buy. As a result, the biggest fight ever seen between...", "blog": [], "keywords": [{"value": "NOVARTIS AG", "name": "organizations"}, {"value": "PROCTER & GAMBLE CO", "name": "organizations"}, {"value": "ASTRAZENECA", "name": "organizations"}, {"value": "GENERIC AND BRAND NAME PRODUCTS", "name": "subject"}, {"value": "HEARTBURN", "name": "subject"}, {"value": "DRUGS (PHARMACEUTICALS)", "name": "subject"}, {"value": "PRICES (FARES, FEES AND RATES)", "name": "subject"}, {"value": "SUITS AND LITIGATION", "name": "subject"}, {"value": "INVENTIONS AND PATENTS", "name": "subject"}, {"value": "OMEPRAZOLE (DRUG)", "name": "subject"}, {"value": "PRILOSEC (DRUG)", "name": "subject"}], "print_page": "1", "type_of_material": "News", "word_count": 1011, "subsection_name": null, "multimedia": []}, {"news_desk": "Metropolitan Desk", "document_type": "article", "_id": "4fd2756e8eb7c8105d834b5c", "headline": {"main": "Downside to Fewer Violent Deaths: Transplant Organ Shortage Grows"}, "pub_date": "2003-08-19T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By RICHARD P\u00c9REZ-PE\u00d1A", "person": [{"lastname": "P\u00c9REZ-PE\u00d1A", "rank": 1, "firstname": "Richard", "organization": "", "role": "reported"}]}, "abstract": "Reduction in violent deaths and death by auto accidents in New York reduces number of organs available for transplanting; 40 percent of dead donors in region are over 50, as compared to 30 percent nationwide, and 6,000 persons around nation die each year waiting for organs; organs from more than 12,000 people, living or dead, are harvested each year, but 82,000 persons are waiting for them; New Yorkers lag behind other regions in donations; photos (L)", "web_url": "http://www.nytimes.com/2003/08/19/nyregion/downside-to-fewer-violent-deaths-transplant-organ-shortage-grows.html", "section_name": "New York and Region", "lead_paragraph": "Whatever you call the opposite of the silver lining in a dark cloud, this is it. In the last dozen years, there have been at least two great positive social trends in America: fewer people die on America's roadways, and fewer people die at the hands of others.", "snippet": "Whatever you call the opposite of the silver lining in a dark cloud, this is it.    In the last dozen years, there have been at least two great positive social trends in America: fewer people die on America's roadways, and fewer people die at the...", "blog": [], "keywords": [{"value": "PEREZ-PENA, RICHARD", "name": "persons"}, {"value": "NEW YORK STATE", "name": "glocations"}, {"value": "NEW YORK CITY", "name": "glocations"}, {"value": "ACCIDENTS AND SAFETY", "name": "subject"}, {"value": "MURDERS AND ATTEMPTED MURDERS", "name": "subject"}, {"value": "TRANSPLANTS", "name": "subject"}, {"value": "ROADS AND TRAFFIC", "name": "subject"}], "print_page": "1", "type_of_material": "News", "word_count": 1254, "subsection_name": null, "multimedia": []}]}, "status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}